AYGPHARMA SAS: public contracts won without a rival in Colombia: 18 uncontested awards; 53% of its awards; 18 without a competition; 0 single bid.
Assay record ASY-CO-0BBJAL701D · Cite as: Assay Systems, “AYGPHARMA SAS: public contracts won without a rival in Colombia”, https://assay-systems.com/register/co/uncontested/s/aygpharma-sas/
AYGPHARMA SAS won 18 of its 34 public contract awards in Colombia without a rival from 2022-11-08 to 2026-03-03: 18 without a competition and 0 after a competition that drew a single bid. 10 buyers awarded it without a rival, the largest E.S.E HOSPITAL SAN RAFAEL DE CAQUEZA with 6.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
E.S.E HOSPITAL SAN RAFAEL DE CAQUEZA gave AYGPHARMA SAS 6 awards: 6 without a competition, 0 after a competition with a single bid. First 2023-02-17, latest 2024-02-12.
HOSPITAL REGIONAL DE MONIQUIRA ESE gave AYGPHARMA SAS 3 awards: 3 without a competition, 0 after a competition with a single bid. First 2022-12-12, latest 2023-02-17.
empresa social del estado región de salud soacha gave AYGPHARMA SAS 8 awards: 2 without a competition, 0 after a competition with a single bid. First 2022-11-08, latest 2026-03-03.
EMPRESA SOCIAL DEL ESTADO HOSPITAL SAN RAFAEL DE FACATATIVA gave AYGPHARMA SAS 1 award: 1 without a competition, 0 after a competition with a single bid. First 2024-01-22, latest 2024-01-22.
HOSPITAL FEDERICO LLERAS ACOSTA DE IBAGUE TOLIMA - EMPRESA SOCIAL DEL ESTADO gave AYGPHARMA SAS 1 award: 1 without a competition, 0 after a competition with a single bid. First 2023-04-03, latest 2023-04-03.
SUBRED INTEGRADA DE SERVICIO DE SALUD CENTRO ORIENTE E.S.E 1 gave AYGPHARMA SAS 2 awards: 1 without a competition, 0 after a competition with a single bid. First 2022-12-26, latest 2025-07-31.
ESE SANTIAGO DE TUNJA gave AYGPHARMA SAS 1 award: 1 without a competition, 0 after a competition with a single bid. First 2024-08-28, latest 2024-08-28.
E.S.E. HOSPITAL EL SALVADOR DE UBATE gave AYGPHARMA SAS 1 award: 1 without a competition, 0 after a competition with a single bid. First 2023-08-10, latest 2023-08-10.
SUBRED INTEGRADA DE SERVICIOS DE SALUD NORTE E.S.E. (OFICIAL) gave AYGPHARMA SAS 3 awards: 1 without a competition, 0 after a competition with a single bid. First 2022-12-13, latest 2022-12-28.
SUBRED INTEGRADA DE SERVICIOS DE SALUD SUR E.S.E gave AYGPHARMA SAS 2 awards: 1 without a competition, 0 after a competition with a single bid. First 2022-11-10, latest 2022-12-28.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2026-02-14 | empresa social del estado región de salud soacha CO1.PCCNTR.9336680 | No competition Contratación régimen especial | Regla aplicable |
| 2025-07-31 | SUBRED INTEGRADA DE SERVICIO DE SALUD CENTRO ORIENTE E.S.E 1 CO1.PCCNTR.8142893 | No competition Contratación régimen especial | Regla aplicable |
| 2024-08-28 | ESE SANTIAGO DE TUNJA CO1.PCCNTR.6674578 | No competition Contratación régimen especial | Regla aplicable |
| 2024-02-12 | empresa social del estado región de salud soacha CO1.PCCNTR.5895678 | No competition Contratación régimen especial | Regla aplicable |
| 2024-02-12 | E.S.E HOSPITAL SAN RAFAEL DE CAQUEZA CO1.PCCNTR.5787107 | No competition Contratación régimen especial | Decreto 092 de 2017 |
| 2024-01-22 | EMPRESA SOCIAL DEL ESTADO HOSPITAL SAN RAFAEL DE FACATATIVA CO1.PCCNTR.5774883 | No competition Contratación régimen especial | Decreto 092 de 2017 |
Every uncontested award in Colombia · All countries · AYGPHARMA SAS in the register
Source: SECOP II, Colombia Compra Eficiente open data (datos.gov.co). Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.